Neilanjan Nandi from Drexel University College of Medicine: Seeing Advancement in the Treatment of C-Diff

MARCH 22, 2016
Adam Hochron

Whether it is medication or fecal microbiota transplantation work in the field of treating clostridium difficile is making great strides every day.

The fact that there are more treatments available makes working with patients considerably easier according to Neilanjan Nandi, MD, from the Drexel University College of Medicine. Conditions like c-diff can have a drastic impact on a patient's daily lives so being able to offer them relief from their symptoms with a wide array of treatment options can help them feel better in many ways according to Nandi. 

Related Coverage >>>
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.